Article info

Concise report
A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis
  1. Correspondence to Beate Skinningsrud, Department of Medical Genetics, Oslo University Hospital, Ullevål, Kirkeveien 166, N-0407 Oslo, Norway; beate.skinningsrud{at}medisin.uio.no
View Full Text

Citation

Skinningsrud B, Lie BA, Husebye ES, et al
A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis

Publication history

  • Accepted August 13, 2009
  • First published September 3, 2009.
Online issue publication 
July 21, 2010

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.